INNOVATIVE HEALTH PRACTICES
ID: BAA-GH-OAA-2024Type: Special Notice
Overview

Buyer

AGENCY FOR INTERNATIONAL DEVELOPMENTAGENCY FOR INTERNATIONAL DEVELOPMENT

NAICS

All Other Professional, Scientific, and Technical Services (541990)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/ef467544c4ee4331b6fac3a72ccc0276/view
Timeline
    Description

    Special Notice: AGENCY FOR INTERNATIONAL DEVELOPMENT is seeking innovative health practices through a Broad Agency Announcement (BAA). The purpose is to co-create, co-design, co-invest, and collaborate on research and development interventions to reduce disease and mortality rates worldwide. Organizations and companies are invited to submit an Expression of Interest (EOI) to generate novel tools and approaches for improved health outcomes in low-and-middle-income countries (LIMIC).

    Point(s) of Contact
    SHARON D DAVIS
    (202) 916-2644
    SHDAVIS@USAID.GOV
    Files
    Title
    Posted
    BAA-GH-OAA-2024 Innovative Health Practices.pdf
    USAID's Broad Agency Announcement seeks participants to collaborate on innovative health research and development interventions aimed at reducing disease and mortality rates in low-and-middle-income countries. It emphasizes co-creation and co-investment from both local and international organizations, aiming to generate effective solutions to pressing global health challenges. The BAA outlines a multi-stage process for submitting Expressions of Interest and developing Concept Papers, leading to potential funding opportunities based on innovative and impactful proposals.
    Lifecycle
    Title
    Type
    INNOVATIVE HEALTH PRACTICES
    Currently viewing
    Special Notice
    Similar Opportunities
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) targeting chemical, biological, radiological, nuclear threats, and emerging infectious diseases, including pandemic influenza. The initiative aims to enhance public health preparedness by fostering partnerships with private organizations, government laboratories, and academic institutions to expedite the development of life-saving MCMs critical for national health security. Proposals will be evaluated based on scientific merit, technological maturity, and regulatory compliance, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties should direct inquiries to BARDA-BAA@hhs.gov for further information.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative research to enhance public health preparedness against various biomedical threats. The initiative encompasses multiple Areas of Interest (AOIs), including the development of medical countermeasures for emerging infectious diseases, repurposing existing drugs for chemical threats, and advancing technologies for at-home diagnostics. Interested parties must have active registration with SAM.gov and are encouraged to engage in pre-submission consultations; abstract submissions are due by specified deadlines, with funding amounts contingent on the quality of proposals and alignment with program goals. For further inquiries, interested vendors can contact the BARDA DCMA DRIVe Team at DRIVeAcquisitions@hhs.gov.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY26 Broad Agency Announcement (BAA) for advanced research and development in regulatory science. This opportunity aims to acquire basic and applied research that supports regulatory science and innovation, focusing on areas such as New Approach Methodologies, Advanced Manufacturing, and Clinical Outcome Assessments, among others. The FDA's initiative is crucial for enhancing scientific knowledge that aids in protecting and promoting public health, particularly for underrepresented populations and in reducing animal testing. Interested parties, including small businesses and academic institutions, are encouraged to submit proposals by February 24, 2026, and can reach out to Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Broad Agency Announcement Emerging Technologies
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army's Combat Capabilities Development Command, has issued a Broad Agency Announcement (BAA) soliciting research proposals for innovative technologies related to emerging weapons, munitions systems, and soldier lethality. This initiative aims to foster competitive selection of proposals that align with the Army's modernization priorities, including advanced materials, artificial intelligence, and logistics, to enhance operational effectiveness and readiness for future challenges. The BAA is continuously open for submissions until December 17, 2025, and interested parties are encouraged to contact the designated Technical Point of Contact, Carlos Quispe, at carlos.f.quispe.civ@army.mil for guidance on proposal preparation. Proposals will be evaluated based on their scientific merit and potential impact on advancing the Army's capabilities.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), has issued a Broad Agency Announcement (BAA) to solicit proposals for innovative research and development in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. This solicitation is open continuously for up to five years and invites proposals from educational institutions, nonprofit organizations, and private industry, focusing on areas such as detection technologies, modeling and simulation, and countermeasures to terrorism. The BAA is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' dominance on the battlefield and homeland defense. Interested parties can contact Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil or Lionel Love at lionel.d.love.civ@army.mil for further information regarding proposal submissions and evaluation criteria.
    Department of Veterans Affairs, VA Innovation Ecosystem (VHAIE); Broad Agency Announcement (BAA); Suicide Prevention
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking innovative solutions through its Broad Agency Announcement (BAA) for the VA Innovation Ecosystem (VHAIE) focused on suicide prevention among Veterans. This initiative aims to source early-stage research, development, prototyping, and piloting of solutions that enhance access to services, reduce costs, improve operational performance, and elevate the quality of care for Veterans and their families. The BAA invites submissions from a diverse range of entities, including private companies, non-profits, and educational institutions, with a structured two-stage submission process for concept papers running from July 15, 2024, to September 30, 2026, and funding limits of $2 million for the prototyping phase and $4 million for the field testing phase. Interested parties can direct inquiries to VHASuicidePreventionBAA@va.gov for further details on submission requirements and evaluation criteria.
    NEEDIPEDIA BROAD AGENCY ANNOUNCEMENT - BAA
    Dept Of Defense
    The Department of Defense, through the Defense Intelligence Agency (DIA), is issuing a Broad Agency Announcement (BAA) titled "NEEDIPEDIA" to solicit innovative ideas from a wide range of qualified sources, including large and small businesses, academic institutions, and independent consultants. The objective of this solicitation is to enhance the agency's operational efficiency and effectiveness, as well as to support its national and international mission requirements through advanced technological capabilities and innovative solutions. This BAA is a follow-on to a previous solicitation and emphasizes the importance of collaboration across various sectors to achieve the agency's goals. Interested parties are encouraged to submit white papers, adhering to specific guidelines, and can reach out to Il Jun Yun at iljun.yun@dodiis.mil or 703-735-6430 for further inquiries. The submission process includes a coversheet and a maximum two-page white paper, with additional details available on the NeedipeDIA Web Portal and SAM.gov.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Dept Of Defense
    The Department of Defense, through the United States Special Operations Command (USSOCOM), is soliciting proposals for the Broad Agency Announcement (BAA) focused on Extramural Biomedical and Human Performance Research and Development, which will be open from August 1, 2023, to July 31, 2028. This initiative aims to enhance military medical capabilities by funding innovative research addressing critical areas such as trauma care, brain health, casualty management, and human performance optimization, with individual project budgets ranging from $700,000 to $5 million. The research funded under this BAA is intended to benefit both military and civilian medical practices, emphasizing the importance of applicable solutions for unique operational environments. Interested organizations, including non-profits and educational institutions, must submit a pre-proposal via the electronic Biomedical Research Application Portal (eBRAP) before being invited to submit a full proposal through Grants.gov, with a total annual funding budget of $10 million available for selected projects. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or Jessee Chege at jessee.t.chege.civ@health.mil.